drugset / Trial / NCT00640809

Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole

NCT00640809

Phase 4 Completed 408 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the small bowel lesion pattern associated with celecoxib alone versus ibuprofen plus omeprazole

Timeline

Start
2003-10
Primary completion
Completion
2004-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 200 mg Oral
Comparator Ibuprofen Small molecule 800 mg Oral
Comparator Omeprazole Other / unclassified 20 mg Oral